...
首页> 外文期刊>Brain, Behavior, and Immunity >Markers of neuroinflammation and neuronal injury in bipolar disorder: Relation to prospective clinical outcomes
【24h】

Markers of neuroinflammation and neuronal injury in bipolar disorder: Relation to prospective clinical outcomes

机译:双相紊乱中神经炎症和神经元损伤的标志:与前瞻性临床结果的关系

获取原文
获取原文并翻译 | 示例
           

摘要

Highlights ? Low CSF levels of YKL-40 predicted mania/hypomania. ? CSF levels of IL-8 and NF-L did not predict long-term clinical outcomes. ? Assessed markers of neuroinflammation did not consistently predict poor clinical outcomes. Abstract Neuroimmune mechanisms have been linked to the pathophysiology of bipolar disorder based on studies of biomarkers in plasma, cerebrospinal fluid (CSF), and postmortem brain tissue. There are, however, no longitudinal studies investigating if CSF markers of neuroinflammation and neuronal injury predict clinical outcomes in patients with bipolar disorder. We have in previous studies found higher CSF concentrations of interleukin-8 (IL-8), monocyte chemoattractant protein 1 (MCP-1/CCL-2), chitinase-3-like protein 1 (CHI3L1/YKL-40), and neurofilament light chain (NF-L) in euthymic patients with bipolar disorder compared with controls. Here, we investigated the relationship of these CSF markers of neuroinflammation and neuronal injury with clinical outcomes in a prospective study. 77 patients with CSF analyzed at baseline were followed for 6–7 years. Associations of baseline biomarkers with clinical outcomes (manic/hypomanic and depressive episodes, suicide attempts, psychotic symptoms, inpatient care, GAF score change) were investigated. Baseline MCP-1 concentrations were positively associated with manic/hypomanic episodes and inpatient care during follow-up. YKL-40 concentrations were negatively associated with manic/hypomanic episodes and with occurrence of psychotic symptoms. The prospective negative association between YKL-40 and manic/hypomanic episodes survived multiple testing correction. Concentrations of IL-8 and NF-L were not associated with clinical outcomes. High concentrations of these selected CSF markers of neuroinflammation and neuronal injury at baseline were not consistently associated with poor clinical outcomes in this prospective study. The assessed proteins may be involved in adaptive immune processes or reflect a state of vulnerability for bipolar disorder rather than being of predictive value for disease progression.
机译:强调 ?低CSF水平的YKL-40预测的躁狂症/ Hypomania。还IL-8和NF-L的CSF水平没有预测长期临床结果。还评估的神经炎性标记并未始终预测临床结果不良。摘要基于血浆,脑脊液(CSF)和后脑组织的生物标志物的研究,摘要神经免疫机制已与双相障碍的病理生理学相关联。然而,没有纵向研究,研究神经引发和神经元损伤的CSF标志物预测双相障碍患者的临床结果。我们在先前的研究中发现了更高的CSF浓度的白细胞介素-8(IL-8),单核细胞化学蛋白1(MCP-1 / CCL-2),几丁质酶-3样蛋白1(CHI3L1 / YKL-40)和神经丝轻链(NF-1)在肠外障碍患者与对照相比。在这里,我们研究了这些CSF标志物与前瞻性研究中的临床结果的神经炎症和神经元损伤的关系。 77例CSF患者在基线分析6-7岁。研究了基线生物标志物与临床结果的关联(躁狂/低级和抑郁发作,自杀企图,精神病症状,住院护理,GAF评分变化)。基线MCP-1浓度与随访期间的躁狂/疥疮发作和住院护理呈正相关。 YKL-40浓度与躁狂/疥疮发作产生负面,并且发生精神症状。 YKL-40和躁狂/奇数发作之间的前瞻性负关联存活多次测试校正。 IL-8和NF-L的浓度与临床结果无关。基线神经炎和神经元损伤的高浓度这些CSF标记与该前瞻性研究中的临床结果不始终如一。评估的蛋白质可以参与适应性免疫过程,或反映双相障碍的脆弱状态,而不是对疾病进展的预测价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号